A Multicenter Study of Cancer Incidence in CHEK2 1100delC Mutation Carriers

The CHEK2 1100delC protein-truncating mutation has a carrier frequency of ~0.7% in Northern and Western European populations and confers an ~2-fold increased risk of breast cancer. It has also been suggested to increase risks of colorectal and prostate cancer, but its involvement with these or other...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Thompson, Deborah, Seal, Sheila, Schutte, Mieke, McGuffog, Lesley, Barfoot, Rita, Renwick, Anthony, Eeles, Rosalind, Sodha, Nayanta, Houlston, Richard, Shanley, Susan, Klijn, Jan, Wasielewski, Marijke, Chang-Claude, Jenny, Futreal, P. Andrew, Weber, Barbara L., Nathanson, Katherine L., Stratton, Michael, Meijers-Heijboer, Hanne, Rahman, Nazneen, Easton, Douglas F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2006
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2714971/
https://ncbi.nlm.nih.gov/pubmed/17164383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-06-0687
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados